Document Detail


Acute cholestatic hepatitis and the sudden rise of the pacing threshold 5 weeks after VVI-pacemaker implantation.
MedLine Citation:
PMID:  8077895     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The patient we describe developed a cholestatic hepatitis and an unusual threshold elevation of about 425%, coincidently, 5 weeks after pacemaker implantation. Lead dislocation, myocardial infarction or metabolic disorder could be excluded as a reason for the pacemaker complication. Neither a biliary obstruction nor an infection of the liver could be found to explain the liver injury. Most probably, both disorders were caused by propafenone (450 mg day-1), withdrawal of the drug resulted in normalization of elevated enzyme and threshold levels.
Authors:
R Schüppel; M Probst
Related Documents :
9124025 - Inappropriate rate response in a vvi-r pacemaker.
7381555 - Myelography with metrizamide in the study of the lumbosacral tract.
3844995 - Indications for and management of cardiac pacemakers.
25250865 - The clinical dilemma of quantifying mechanical left ventricular dyssynchrony for cardia...
17913265 - Catastrophic early drug eluting stents thrombosis and aspirin hypersensitivity.
20447535 - Prospective evaluation of the prognostic implications of improved assay performance wit...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of internal medicine     Volume:  236     ISSN:  0954-6820     ISO Abbreviation:  J. Intern. Med.     Publication Date:  1994 Sep 
Date Detail:
Created Date:  1994-09-30     Completed Date:  1994-09-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8904841     Medline TA:  J Intern Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  353-6     Citation Subset:  IM    
Affiliation:
Medical Clinic, Herrsching, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Cardiac Pacing, Artificial*
Cholestasis / complications,  physiopathology*
Electrocardiography
Hepatitis / etiology,  physiopathology*
Humans
Male
Propafenone / adverse effects*
Substance Withdrawal Syndrome / complications*
Time Factors
Chemical
Reg. No./Substance:
54063-53-5/Propafenone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association of isolated hypogonadotropic hypogonadism, pronounced hypodontia and the Wolff-Parkinson...
Next Document:  An interaction between Gemfibrozil and alpha 1-antitrypsin.